29.10
Arcutis Biotherapeutics Inc Azioni (ARQT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
23.21%
129.86
|
105.40 | 129.50 | 99.22 | 81.50 |
| Cost Of Revenue |
11.80%
10.94
|
9.784 | 11.69 | 8.685 | 7.492 |
|
|
10.88%
82.14
|
74.08 | - | - | - |
| Costs And Expenses |
0.92%
113.43
|
114.49 | 111.12 | 90.69 | 96.11 |
| Operating Income/Loss |
280.76%
16.43
|
-9.089 | 18.39 | 8.526 | -14.61 |
| Nonoperating Income/Loss |
-1.284
|
- | - | - | - |
| Income Tax Expense/Benefit |
46.24%
0.136
|
0.093 | 0.47 | 0.08 | 0.342 |
| Net Income/Loss |
232.88%
15.01
|
-11.29 | 17.39 | 7.41 | -15.89 |
| Basic Average Shares |
100.79K%
130.52
|
0.1294 | 0.343 | 127.62 | 127.00 |
| Diluted Average Shares |
104.95K%
135.90
|
0.1294 | 0.343 | 132.88 | 127.00 |
| Basic Earnings Per Share |
222.22%
0.11
|
-0.09 | 0.13 | 0.06 | -0.13 |
| Diluted Earnings Per Share |
222.22%
0.11
|
-0.09 | 0.13 | 0.06 | -0.13 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):